Clinical grade lentiviral vector purification and quality control requirements-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical grade lentiviral vector purification and quality control requirements

Published:2022-03-15 Issue:12 Volume:45 Page:2093-2101
ISSN:1615-9306
Container-title:Journal of Separation Science
language:en
Short-container-title:J of Separation Science

Author:

Shi Ruina¹,Jia Shenghua²,Liu Huwei³⁴^ORCID,Nie Honggang⁴⁵^ORCID

Affiliation:

1. Quality Department Beijing Imunopharm Pharmaceuticals Co., Ltd. Beijing P. R. China

2. Research and Development Center Beijing Imunopharm Pharmaceuticals Co., Ltd. Beijing P. R. China

3. College of Life Sciences Wuchang University of Technology Wuhan P. R. China

4. Beijing National Laboratory for Molecular Sciences College of Chemistry and Molecular Engineering Peking University Beijing P. R. China

5. Analytical Instrumental Center Peking University Beijing P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Filtration and Separation,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jssc.202100937

Reference85 articles.

1. Pathogenesis of lentivirus infections

2. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

3. Purification and characterization of retrovirus vector particles by rate zonal ultracentrifugation

4. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.

5. Challenges of up-scaling lentivirus production and processing

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiangle Light Scattering as a Lentivirus Purification Process Analytical Technology;Analytical Chemistry;2024-05-28

2. Manufacturing Cell and Gene Therapies: Challenges in Clinical Translation;Annals of Laboratory Medicine;2024-02-16

3. Duchenne muscular dystrophy treatment with lentiviral vector containing mini‐dystrophin gene in vivo;MedComm;2024-01

4. Lentiviral Vectors for Ocular Gene Therapy;Pharmaceutics;2022-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3